What is ELTROMBOPAG 25 MG REVOLADE?
ELTROMBOPAG 25 MG REVOLADE tablet is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. It is also used to treat severe aplastic anemia.
How can be used ELTROMBOPAG 25 MG REVOLADE?
Eltrombopag was at first supported by the U.S. Food and Drug Administration (FDA) on November 20, 2008, for the therapy of thrombocytopenia in individuals with ongoing invulnerable (idiopathic) thrombocytopenic purpura who have had an inadequate reaction to corticosteroids, immunoglobulin treatment, or splenectomy.
Eltrombopag, sold under the brand name Promacta among others, is a prescription used to treat thrombocytopenia (unusually low platelet checks) and serious aplastic frailty.
It is a thrombopoietin receptor agonist. Eltrombopag was found because of examination cooperation among GlaxoSmithKline and Ligand Pharmaceuticals.
Revolade 25mg Tablet is a thrombopoietin agonist. It works by stimulating the formation of new platelets in the blood. The function of platelets is to help reduce bleeding.
It should be taken in a dose and duration as advised by the doctor. You may take it on an empty stomach. This medicine is to be swallowed as a whole. Do not chew, crush or break it. Inform your doctor if you have any known allergies to this medication.
Sides effects of ELTROMBOPAG 25 MG REVOLADE:
The common side effects include nausea, vomiting, or diarrhea. Inform your doctor if you are pregnant or breastfeeding or suffering from liver diseases as a dose adjustment may be required. It is safe to use in patients suffering from kidney diseases. It is not advised to drive after taking this medicine as you may feel dizzy making you less alert. For more details click here.
Trade Name:– REVOLADE
Manufacturer: NOVARTIS
Presentation: Tablet
Strength: 25mg
